Skip to Main Content

Paper Details

How much and how long: tyrosine kinase inhibitor therapy in chronic myeloid leukemia.
Clin Lymphoma Myeloma Leuk
6
2010
Author NameAffiliation
Elie TraerOregon Health & Science University Knight Cancer Institute
  • 1 - 1

Datasets

Release 1.2